ESC Premium Access

Role of clopidogrel loading dose in patients undergoing transcatheter aortic valve implantation: results from the BRAVO-3 randomized trial

Topic: Non coronary cardiac interventions

Congress Session

About the speaker

Doctor Vincent Johan Nijenhuis

St Antonius Hospital, Nieuwegein (Netherlands (The))
0 follower

6 more presentations in this session

Transcatheter aortic valve implantation: efficacy, safety and mortality at 30-days to 1-year from a nationwide eight year registry

Speaker: Doctor P. Canas da Silva (Lisbon, PT)

Thumbnail

Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry

Speaker: Doctor P. Canas da Silva (Lisbon, PT)

Thumbnail

Impact of residual coronary artery disease on patients undergoing TAVI: a multicenter study

Speaker: Doctor S. Taha (Assiut, EG)

Thumbnail

Effect of body mass index on mortality after transcatheter aortic valve implantation: J-shaped curve.

Speaker: Ms R. GONZALEZ FERREIRO (Vigo, ES)

Thumbnail

Acute kidney injury following transcatheter aortic valve implantation: does it affect long-term outcomes?

Speaker: Doctor A. Bacelar (Sao Paulo, BR)

Thumbnail

Access the full session

Current data on TAVI outcomes

Speakers: Doctor V. Nijenhuis, Doctor P. Canas da Silva, Doctor P. Canas da Silva, Doctor S. Taha, Ms R. GONZALEZ FERREIRO...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk